Longitudinal Analysis of the Care Pathway of Patients with Lumbar Spinal Stenosis in the US
DOI: https://doi.org/10.2147/jpr.s454887
IF: 2.8319
2024-06-05
Journal of Pain Research
Abstract:Ramana K Naidu, 1 Oth V Tran, 2 Michael E Schatman 3, 4 1 Pain Management, Marin Health Medical Center, Greenbrae, CA, USA; 2 Health Economics & Outcomes Research, Boston Scientific, Marlborough, MA, USA; 3 Department of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY, USA; 4 Department of Population Health – Division of Medical Ethics, NYU Grossman School of Medicine, New York, NY, USA Correspondence: Oth V Tran, Email Background: Evidence regarding the frequency and timing of treatment for lumbar spinal stenosis (LSS) fails to offer clear consensus. We describe the LSS care journey from initial diagnosis to first surgical intervention. Methods: Using Medicare claims database from 2009 through 2020, we identified patients who were diagnosed with LSS. The use and timing of conservative and surgical treatments during the entire follow-up from the initial diagnosis were reported. Results: Of the 143,849 patients identified, 68% received conservative care within 8.4 months and 25.3% received a surgical or minimally invasive intervention over 5.7 years following initial diagnosis, with 12.6% undergoing open decompression alone, 10.2% undergoing open decompression with fusion, and 5.1% undergoing fusion surgery alone. Fewer than 1% were provided with interspinous spacers or a percutaneous image-guided lumbar decompression. Conclusion: Approximately three-quarters of patients in the study received no surgical or non-invasive interventions for approximately six years following diagnosis with LSS. Keywords: lumbar spinal stenosis, interspinous spacer, lumbar decompression, chronic pain Lumbar spinal stenosis (LSS) represents a narrowing of the spinal canal to the point that the neurovascular structures of the spine are compressed. 1,2 In addition to congenital causes, LSS may stem from degenerative diseases or conditions such as spondylolisthesis and disc herniation. 2 While patients with LSS can be asymptomatic, 3 for many patients, LSS imposes a significant decrement on health-related quality of life, 4 commonly due to neurogenic intermittent claudication (NIC) that manifests as pain, discomfort, and/or weakness in the back and legs, as well as difficulty walking. 2 LSS is estimated to affect 11% of the general population and 39% of those in primary and secondary care, with prevalence increasing with age. 5,6 As a result, global prevalence will invariably rise as the duration of global life expectancy grows. First-line treatment for LSS typically begins with non-operative "conservative care" (CC), which typically consists of pain medications, physical therapy, and epidural spinal injections. 7,8 When CC fails to relieve symptoms, surgical options are often considered, including the placement of interspinous spacers and direct or indirect decompression of the spinal canal with or without fusion, as well as traditional spinal surgery to decompress the spinal canal and retain stability. 7 Minimally invasive treatments, such as interspinous spacers, can be an appropriate treatment for those with mild-to-moderate LSS, 9 while surgical options are "indicated in patients whose symptoms persist despite conservative measures and demonstrate surgically correctable pathologies" (page 20). 10 Surgical interventions such as decompression and fusion can be costly, and patients face a higher risk of surgical complications compared to minimally invasive procedures including a placement of an interspinous spacer. 11–15 Algorithms and recommendations exist for consideration of these procedures, 8 but there are limited data elucidating how many (and when) patients receive an initial surgical intervention in routine clinical practice. 3 Given the variety of available treatment options, a description of the real-world care pathways of LSS patients provides a better understanding of how often these treatments are used in clinical practice. This study examines the patient care journey from initial LSS diagnosis to first surgical intervention using healthcare claims to assess longitudinal healthcare resource utilization associated with LSS. This study used the Medicare 5% Standard Analytical Files (SAF) administrative claims data from 2009 through 2020 to perform a retrospective analysis of patients diagnosed with LSS. The Medicare data were drawn from a randomly selected 5% sample of all Medicare Fee-for-Service beneficiaries that allows for patients to be followed longitudinally over multiple years. The International Classification of Diseases, Ninth and Tenth Revision, Clinical Modific -Abstract Truncated-
clinical neurology